Advances in assays of matrix metalloproteinases (MMPs) and their inhibitors

被引：12
作者：
Cheng, Xian-Chao [1 ]
Fang, Hao [1 ]
Xu, Wen-Fang [1 ]
机构：
[1] Shandong Univ, Inst Med Chem, Sch Pharmaceut Sci, Jinan 250012, Peoples R China
来源：
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY | 2008年 / 23卷 / 02期
关键词：
matrix metalloproteinases; inhibitors; assays;
D O I：
10.1080/14756360701511292
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Matrix metalloproteinases (MMPs) play an important role in many physiological and pathological processes. To assay the activities of MMPs is important in diagnosis and therapy of the MMPs associated diseases, such as neoplastic, rheumatic and cardiovascular diseases. Several assay systems have been developed, which include bioassay, zymography assay, immunoassay, fluorimetric assay, radio isotopic assay, phage-displayed assay, multiple-enzyme/multiple-reagent assay and activity-based profiling assay. The principle, application, advantage and disadvantage of these assays have been reviewed in this article.
引用
收藏
页码：154 / 167
页数：14
相关论文
共 115 条
[61]   Analysis of matrix metalloproteinase triple-helical peptidase activity with substrates incorporating fluorogenic L- or D-amino acids [J].
Lauer-Fields, JL ;
Kele, M ;
Sui, GD ;
Nagase, H ;
Leblanc, RM ;
Fields, GB .
ANALYTICAL BIOCHEMISTRY, 2003, 321 (01) :105-115
[62]   Triple-helical peptide analysis of collagenolytic protease activity [J].
Lauer-Fields, JL ;
Fields, GB .
BIOLOGICAL CHEMISTRY, 2002, 383 (7-8) :1095-1105
[63]   Kinetic analysis of matrix metalloproteinase activity using fluorogenic triple-helical substrates [J].
Lauer-Fields, JL ;
Broder, T ;
Sritharan, T ;
Chung, L ;
Nagase, H ;
Fields, GB .
BIOCHEMISTRY, 2001, 40 (19) :5795-5803
[64]   Reverse zymography using fluorogenic substrates for protease inhibitor detection [J].
Le, QT ;
Ohashi, A ;
Hirose, S ;
Katunuma, N .
ELECTROPHORESIS, 2005, 26 (06) :1038-1045
[65]   Zymography: A single-step staining method for quantitation of proteolytic activity on substrate gels [J].
Leber, TM ;
Balkwill, FR .
ANALYTICAL BIOCHEMISTRY, 1997, 249 (01) :24-28
[66]   Analytical aspects regarding the measurement of metalloproteinases and their inhibitors in blood [J].
Lein, M ;
Nowak, L ;
Jung, K ;
Koenig, F ;
Lichtinghagen, R ;
Schnorr, D ;
Loening, SA .
CLINICAL BIOCHEMISTRY, 1997, 30 (06) :491-496
[67]   Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis [J].
Leppert, D ;
Lindberg, RLP ;
Kappos, L ;
Leib, SL .
BRAIN RESEARCH REVIEWS, 2001, 36 (2-3) :249-257
[68]   Matrix metalloproteinases and atherosclerotic plaque instability [J].
Loftus, IM ;
Naylor, AR ;
Bell, PRF ;
Thompson, MM .
BRITISH JOURNAL OF SURGERY, 2002, 89 (06) :680-694
[69]   Assays of matrix metalloproteinases (MMPs) activities: a review [J].
Lombard, C ;
Saulnier, J ;
Wallach, J .
BIOCHIMIE, 2005, 87 (3-4) :265-272
[70]   Calibrating gelatin zymograms with human gelatinase standards [J].
Makowski, GS ;
Ramsby, ML .
ANALYTICAL BIOCHEMISTRY, 1996, 236 (02) :353-356
234567891011